Statistics
Publications
3
Citations
137
H-Index
3
Active since
2022
Affiliations
James Kurasawa is an author at AstraZeneca (United Kingdom) specializing in non-small cell lung cancer treatment, t cell responses to tumors, and non-small cell lung cancer immunotherapy.
Publications per year
2022–2024
3
3
Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC
Eric Tu, Kelly McGlinchey, Jixin Wang et al. · JCI Insight · 2022 · 109 citations · Full text
Life Sciences, Immunology, Oncology +17
1–3 of 3